SPC Financial Inc’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$730K Sell
7,286
-8
-0.1% -$721 0.06% 141
2025
Q2
$605K Buy
7,294
+34
+0.5% +$2.71K 0.05% 158
2025
Q1
$589K Buy
7,260
+2,479
+52% +$222K 0.05% 157
2024
Q4
$431K Sell
4,781
-1,730
-27% -$168K 0.04% 182
2024
Q3
$643K Sell
6,511
-161
-2% -$15.8K 0.06% 144
2024
Q2
$619K Buy
6,672
+72
+1% +$6.46K 0.06% 130
2024
Q1
$626K Buy
6,600
+3,838
+139% +$356K 0.06% 132
2023
Q4
$247K Sell
2,762
-4,848
-64% -$360K 0.03% 199
2023
Q3
$556K Buy
7,610
+138
+2% +$11K 0.06% 133
2023
Q2
$622K Buy
7,472
+325
+5% +$27.2K 0.07% 121
2023
Q1
$545K Buy
+7,147
New +$593K 0.06% 126
2022
Q4
Sell
-7,881
Closed -$625K 212
2022
Q3
$625K Sell
7,881
-385
-5% -$32.5K 0.08% 109
2022
Q2
$614K Sell
8,266
-1,942
-19% -$146K 0.08% 112
2022
Q1
$917K Buy
10,208
+8,394
+463% +$775K 0.11% 80
2021
Q4
$203K Sell
1,814
-7,846
-81% -$946K 0.02% 186
2021
Q3
$1.21M Buy
9,660
+530
+6% +$68.3K 0.15% 68
2021
Q2
$1.24M Buy
9,130
+1,524
+20% +$200K 0.15% 66
2021
Q1
$1.03M Sell
7,606
-7,806
-51% -$1.17M 0.14% 67
2020
Q4
$2.17M Buy
+15,412
New +$1.97M 0.31% 52

Other funds holding XBI

SPC Financial Inc's XBI Position: Q3 2025 in Review

SPC Financial Inc reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.11% in Q3 2025, selling an estimated $721 and leaving 7,286 shares worth $730K. The position accounts for 0.06% of the portfolio, ranked #141.

SPC Financial Inc first reported a position in XBI in Q4 2020 and has held it in 19 quarters since. The position peaked at $2.17M in Q4 2020. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

  • SPC Financial Inc held 7,286 shares of State Street SPDR S&P Biotech ETF worth $730K as of Q3 2025.
  • SPC Financial Inc sold 8 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $721.
  • State Street SPDR S&P Biotech ETF made up 0.06% of SPC Financial Inc's portfolio in Q3 2025, its #141 holding.
  • SPC Financial Inc first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 19 quarters since.
  • SPC Financial Inc's State Street SPDR S&P Biotech ETF position peaked at $2.17M in Q4 2020.
  • 656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on SPC Financial Inc's 13F filing for Q3 2025, filed 5 Nov 2025.